The markets extended its losses to close lower with the Dow dropping 65 points to 20,663 on the final trading day of the first quarter. Nasdaq slipped 2 points to 5,911.
On the upside
Affiliates of investment fund New Mountain Partners will take TRC Companies (NYSE: TRR) private in an all cash transaction valued at a premium of $17.55 per common share.
Dicerna Pharmaceuticals (Nasdaq: DRNA) narrowed fourth quarter losses more than expected.
Fang Holdings (NYSE: SFUN) narrowed losses for the fourth quarter and announced that the company would return to its open-platform strategy.
On the downside
A district court invalidated four of Acorda Therapeutics' (Nasdaq: ACOR) patents pertaining to AMPYRA .
Proteostasis Therapeutics (Nasdaq: PTI) widened losses for the fourth quarter.
DarioHealth (Nasdaq: DRIO) priced its public offering of 1.45 million common shares at the discounted price of $3.10 per share.
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 index lost 5 points to 2,362. Bitcoin soared $32 to $1067.